Connection

Silvio Danese to Antirheumatic Agents

This is a "connection" page, showing publications Silvio Danese has written about Antirheumatic Agents.
Connection Strength

0.075
  1. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017 12 23; 390(10114):2779-2789.
    View in: PubMed
    Score: 0.060
  2. Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents. BioDrugs. 2017 Jun; 31(3):223-237.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.